Welcome back to Week in Review! Tons of news from this week for you, including a hacking group that's linked to the Spanish ...

Regeneron (NASDAQ: REGN) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its previous ...

Recapping some of the most talked-about news this week from the nation and around the world – in case you missed it.

Missouri Attorney General Andrew Bailey is alerting residents after biotechnology company 23andMe filed for bankruptcy in ...

Republican Sen. John Cornyn and Democratic Sen. Amy Klobuchar are rolling out a measure to protect sensitive genetic data ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

We recently published a list of Jim Cramer Reveals “Quiet” Stock That Goes Up In This List Of 12 Stocks. In this article, we ...

There is nothing more inherently unique and personal to an individual than his or her DNA. Unlike many other types of personal information, a ...

Tarrytown-based Regeneron Pharmaceuticals, Inc. has announced it has been named the successful bidder in the bankruptcy ...

In the latest episode of Touching Base, we discuss big news in CRISPR along with updates in the business side of biotech.

The price tag of this acquisition suggests that the value of genetic data is declining. Back in 2018, the drug company GSK ...

Regeneron acquires bankrupt 23andMe for $256M, taking over its DNA database and services while pledging to uphold privacy ...